FDA Panel Backs Amgen’s Nplate For Chronic Immune Thrombocytopenic Purpura
This article was originally published in The Pink Sheet Daily
Executive Summary
The platelet producer could have an important role in chronic ITP management, Oncologic Drugs Advisory Committee says.